BioTechX Europe 2025

We are glad to return to BioTechX Europe in Basel. Meet our BioPharma team and learn how we help BioPharma companies address challenges throughout the drug development continuum with diagnostics and data solutions tailored to their needs, bringing more effective drugs to the right patients.

If you are attending, join us on October 6^th at 14:50, in the Big Data in Oncology track, for an engaging talk about how SOPHiA GENETICS is building a world where clinicians make faster, more informed decisions, and every patient contributes to a smarter and more equitable future in medicine

“Unlocking the Power of Data: AI-Driven Insights for Precision Medicine”

Guillaume Cettou, Global Head of Data Partnerships, SOPHiA GENETICS

You’ll get to explore howAI and collective intelligence are translating vast amounts of data into actionable insights, enabling clinicians to make more informed decisions and improving outcomes across borders.

Learn how AI is redefining real-world healthcare by transforming data complexity into valuable insights that unlock groundbreaking medical advancements and reshape care delivery.
Explore how a connected network of healthcare institutions is powering global collaboration by creating a feedback loop of knowledge, leading to patient benefits worldwide.
Discover how a decentralized, cloud-based AI technology is bridging the gap in cancer care, paving the way for a connected future, where the patients of today are helping the patients of tomorrow.

Book a Meeting

Name

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Institution(Required)

Job Function(Required)

Area of Interest(Required)

Email(Required)

Phone(Required)

Country(Required)

Select US State

By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy

Marketing Opt-In

I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

This field is hidden when viewing the form

Job Title/Industry(Required)

CAPTCHA

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expresseda during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services